首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1836316

感覺異常治療市場，按類型、按治療、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Paresthesia Treatment Market, By Type, By Treatment, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2025年09月04日 | 出版商:

AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年感覺異常治療市場規模價值 60.521 億美元，2025 年至 2032 年的複合年成長率為 4.20%。

感覺異常是一種以灼熱感、刺痛感、麻木感或刺痛感等感覺為特徵的疾病，主要影響手、腳、手臂或腿等身體部位。這種疾病最常見的原因是神經損傷或壓迫，導致正常的訊號傳輸中斷，或由腦部血流不穩定引起。感覺異常是多種潛在疾病的症狀，包括第1型和第2型糖尿病、維生素缺乏症、神經系統疾病和腕隧道症候群。

感覺異常治療市場-市場動態

慢性病發生率上升

慢性疾病的盛行率不斷上升，推動了感覺異常治療市場的發展。糖尿病、多發性硬化症和關節炎常會造成神經損傷，導致刺痛、麻木和疼痛等感覺異常症狀。隨著確診這些疾病的人數不斷增加，對有效緩解感覺異常的治療方法的需求也日益成長。這種需求的激增迫使醫療保健提供者和製藥公司投資於創新方法和標靶療法。對改善患者生活品質和有效控制症狀的重視加速了市場成長，推動了這些慢性疾病治療方案的進步。

感覺異常治療市場-細分分析：

全球感覺異常治療市場根據類型、治療、最終用戶和地區進行細分。

根據類型，市場分為兩類：急性感覺異常和慢性感覺異常。由於全球老齡人口迅速增加，急性感覺異常細分市場預計將在研究期間成長最快，而老齡人口更容易患上由退化性脊椎疾病和關節炎引起的神經壓迫等疾病。此外，醫療技術的快速進步帶來了更有效、更侵入性的急性感覺異常治療方法的開發，預計將推動細分市場的成長。根據世界衛生組織的數據，2020 年 60 歲以上的人口約有 10 億，預計到 2030 年將上升到 14 億以上。此外，到 2050 年，80 歲及以上人口數量將翻倍，達到 21 億以上。

根據治療類型，市場可分為四類：免疫抑制劑、外用藥膏、抗病毒藥物和抗驚厥藥物。就收入佔有率而言，抗驚厥藥物將在2025年佔據市場主導地位，這得益於其在治療神經性疼痛（常伴有感覺異常）方面的高效性，以及其更佳的安全性，使其比其他類型的藥物更適合長期使用。此外，領先的製藥公司正增加對新型抗驚厥藥物的研發投入，以期提高療效並減少副作用，同時探索其與其他療法（例如物理療法和其他類型的藥物）的聯合應用及其潛力，這可能會拓寬治療選擇，並進一步推動抗驚厥藥物市場的發展。

感覺異常治療市場—地理洞察

北美佔據全球市場主導地位。該地區市場的成長主要得益於治療技術進步的普及，以及該地區多種神經系統疾病的盛行率上升。此外，該地區擁有完善的監管機構，例如美國食品藥物管理局 (FDA)，為新醫療器材和新療法的核准提供了清晰的路徑，鼓勵了該領域的創新，並為市場創造了巨大的成長潛力。例如，2022年4月，BioXcel Therapeutics宣布FDA已批准IGALMI舌下膜，該膜專為急性躁動治療設計。這是FDA核准的首個用於治療中度至重度躁動患者的口溶性舌下膜。

預計亞太市場在預測期內成長最快。該市場主要受完善的醫療保健系統和對神經系統疾病的廣泛認知所推動。此外，醫療保健投資增加等因素預計將在預測期內推動亞太地區的市場成長。例如，2024年3月，Wipro GE Healthcare宣布投資超過8億美元，以因應不斷擴大的國內外醫療保健市場。

感覺異常治療市場-競爭格局：

感覺異常治療市場競爭激烈，許多全球和地區參與者爭奪市場佔有率。產品創新、策略合作、併購以及經銷網路的擴張都會影響市場競爭力。各公司正致力於開發新療法並改進現有治療方案，以改善患者療效並獲得競爭優勢。此外，研發和臨床試驗的投資對於將新型有效療法推向市場至關重要。感覺異常治療市場的主要參與者包括史賽克公司、百特國際公司、生物醫學研究有限公司和波士頓科學公司。

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美感覺異常治療主要製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模和預測（按產品類型）
- 北美市場規模及預測（按治療類型）
- 北美市場規模及預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲感覺異常治療主要製造商
- 歐洲市場規模及預測（按國家/地區）
- 歐洲市場規模和預測（按產品類型）
- 歐洲市場規模及預測（按治療類型）
- 歐洲市場規模及預測（按最終用戶）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 歐洲其他地區
亞太地區（APAC）
- 概述
- 亞太地區感覺異常治療主要製造商
- 亞太地區市場規模及預測（依國家）
- 亞太地區市場規模及預測（依產品類型）
- 亞太地區市場規模及預測（依治療類型）
- 亞太地區市場規模及預測（依最終用戶）
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 亞太地區其他地區
拉丁美洲（LATAM）
- 概述
- 拉丁美洲感覺異常治療主要製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模及預測（依產品類型）
- 拉丁美洲市場規模及預測（依治療類型）
- 拉丁美洲市場規模及預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲（MEA）
- 概述
- 中東和非洲感覺異常治療主要製造商
- MEA 市場規模及預測（依國家/地區）
- MEA 市場規模及預測（依產品類型）
- MEA 市場規模及預測（以處理方式）
- MEA 市場規模及預測（依最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其餘地區

第 11 章：關鍵供應商分析-感覺異常治療產業

競爭基準化分析
- Competitive Dashboard
- Competitive Positioning
公司簡介
- Stryker Corporation
- Baxter International Inc.
- Bio-Medical Research Ltd.
- Boston Scientific Corporation
- Cipla Ltd.
- ElectroCore LLC
- Abbott Laboratories
- EnteroMedics Inc.
- Nevro Corporation
- Medtronic Plc
- Omron Healthcare Inc.
- Pfizer
- St. Jude Medical LLC
- Stimwave LLC
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV5606

Paresthesia Treatment Market size was valued at US$ 6,052.10 Million in 2024, expanding at a CAGR of 4.20% from 2025 to 2032.

Paresthesia is a medical condition characterized by sensations like burning, tingling, numbness, or prickling that primarily affect various body parts such as the hands, feet, arms, or legs. The condition is most commonly caused by nerve damage or compression, which disrupts normal signal transmission, or by inconsistent blood flow to and from the brain. Paresthesia is a symptom of a variety of underlying medical conditions, including type 1 and type 2 diabetes, vitamin deficiencies, neurological disorders, and carpal tunnel syndrome.

Paresthesia Treatment Market- Market Dynamics

Increasing Incidences of Chronic Illnesses

The rising prevalence of chronic illnesses is driving the paresthesia treatment market. Diabetes, multiple sclerosis, and arthritis frequently cause nerve damage, resulting in paresthesia symptoms such as tingling, numbness, and pain. As the number of people diagnosed with these disorders rises, so does the demand for effective treatments to relieve paresthesia. This surge in demand forces healthcare providers and pharmaceutical companies to invest in novel approaches and targeted therapies. The primary focus on improving patient quality of life and effectively managing symptoms accelerates market growth, driving advancements in treatment options for these chronic conditions.

Paresthesia Treatment Market- Key Insights

According to our research analyst's analysis, the global market is expected to grow at a compound annual growth rate (CAGR) of approximately 4.20% during the 2025-2032 forecast period.

According to type segmentation, the acute paresthesia segment is expected to grow at the fastest rate during the study period.

The anticonvulsants segment held the largest share of the market in 2025, according to treatment segmentation.

In 2025, North America was the top revenue-generating region by region.

Paresthesia Treatment Market- Segmentation Analysis:

The Global Paresthesia Treatment Market is segmented on the basis of Type, Treatment, End-User, and Region.

The market is divided into two categories based on Type: Acute Paresthesia, and Chronic Paresthesia. The acute paresthesia segment is expected to grow the most during the study period, owing to the rapid increase in the global aging population, which is more likely to suffer from conditions such as nerve compression caused by degenerative spinal conditions and arthritis. Furthermore, rapid advances in medical technology, which are leading to the development of more effective and less invasive treatment options for acute paresthesia, are expected to drive segment market growth. According to the World Health Organization, there were approximately 1 billion people over the age of 60 in 2020, and this figure is expected to rise to over 1.4 billion by 2030. Furthermore, the number of people aged 80 and up will double by 2050, reaching over 2.1 billion.

The market is divided into four categories based on Treatment: Immunosuppressants, Topical Creams, Antivirals, and Anticonvulsants. In terms of revenue share, the anticonvulsants segment dominates the market in 2025, owing to their high effectiveness in managing neuropathic pain, which frequently involves paresthesia, as well as their more favorable safety profile, which makes them suitable for long-term use over other types of medications. Furthermore, leading pharmaceutical companies are increasingly investing heavily in the development of new anticonvulsant medications with improved efficacy and fewer side effects, as well as exploring their use and potential in conjunction with other treatments such as physical therapy and other types of medications, which is likely to broaden treatment options and further drive the anticonvulsant segment.

Paresthesia Treatment Market- Geographical Insights

North America dominates the global market. The regional market growth is primarily due to increased adoption of technological advances in treatment techniques and a higher prevalence of several neurological conditions throughout the region. Furthermore, the region has well-established regulatory bodies such as the FDA, which provides a clear path for the approval of new medical devices and treatments, encouraging innovation in this field and creating enormous growth potential for the market. For example, in April 2022, BioXcel Therapeutics announced that the FDA had approved the IGALMI Sublingual Film, which is specifically designed for the acute treatment of agitation. This is the first FDA-approved orally dissolving sublingual film designed for moderate to severe agitation in patients.

The Asia Pacific market is expected to grow the fastest during the forecast period. The market is primarily driven by a well-established healthcare system and widespread awareness of neurological disorders. In addition, factors such as increased healthcare investment and others are expected to drive market growth in the Asia Pacific region over the forecast period. For instance, in March 2024, Wipro GE Healthcare announced an investment of more than USD 800 million to address the expanding domestic and international healthcare markets.

Paresthesia Treatment Market- Competitive Landscape:

The paresthesia treatment market is characterized by a competitive landscape, with many global and regional players vying for market share. Product innovation, strategic collaborations, mergers and acquisitions, and expanding distribution networks all have an impact on market competitiveness. Companies are focusing on developing new therapies and improving existing treatment protocols in order to improve patient outcomes and gain a competitive advantage. Additionally, investments in R&D and clinical trials are critical for bringing new and effective treatments to market. Major players in the paresthesia treatment market include Stryker Corporation, Baxter International Inc., Bio-Medical Research Ltd., and Boston Scientific Corporation.

Recent Developments:

In October 2023, Boston Scientific Corporation received approval from the U.S. FDA for usage of the Wave Writer Alpha Spinal Cord Stimulator (SCS) Systems to treat painful diabetic peripheral neuropathy (DPN).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PARESTHESIA TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Stryker Corporation
Baxter International Inc.
Bio-Medical Research Ltd.
Boston Scientific Corporation
Cipla Ltd.
ElectroCore LLC
Abbott Laboratories
EnteroMedics Inc.
Nevro Corporation
Medtronic Plc
Omron Healthcare Inc.
Pfizer
St. Jude Medical LLC
Stimwave LLC
Others

GLOBAL PARESTHESIA TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Acute Paresthesia
Chronic Paresthesia

GLOBAL PARESTHESIA TREATMENT MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

Immunosuppressants
Topical Creams
Antivirals
Anticonvulsants

GLOBAL PARESTHESIA TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnosis Centers
Clinics

GLOBAL PARESTHESIA TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Paresthesia Treatment Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Paresthesia Treatment Market Snippet by Product Type
- 2.1.2. Paresthesia Treatment Market Snippet by Treatment
- 2.1.3. Paresthesia Treatment Market Snippet by End-User
- 2.1.4. Paresthesia Treatment Market Snippet by Country
- 2.1.5. Paresthesia Treatment Market Snippet by Region
2.2. Competitive Insights

3. Paresthesia Treatment Key Market Trends

3.1. Paresthesia Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Paresthesia Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Paresthesia Treatment Market Opportunities
3.4. Paresthesia Treatment Market Future Trends

4. Paresthesia Treatment Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Paresthesia Treatment Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Paresthesia Treatment Market Landscape

6.1. Paresthesia Treatment Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Paresthesia Treatment Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Acute Paresthesia
- 7.1.3. Chronic Paresthesia

8. Paresthesia Treatment Market - By Treatment

8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment, 2024 & 2032 (%)
- 8.1.2. Immunosuppressants
- 8.1.3. Topical Creams
- 8.1.4. Antivirals
- 8.1.5. Anticonvulsants

9. Paresthesia Treatment Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Diagnosis Centers
- 9.1.4. Clinics

10. Paresthesia Treatment Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Paresthesia Treatment Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Paresthesia Treatment Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Paresthesia Treatment Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Paresthesia Treatment Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Paresthesia Treatment Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Paresthesia Treatment Industry

11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Stryker Corporation
- 11.2.2. Baxter International Inc.
- 11.2.3. Bio-Medical Research Ltd.
- 11.2.4. Boston Scientific Corporation
- 11.2.5. Cipla Ltd.
- 11.2.6. ElectroCore LLC
- 11.2.7. Abbott Laboratories
- 11.2.8. EnteroMedics Inc.
- 11.2.9. Nevro Corporation
- 11.2.10. Medtronic Plc
- 11.2.11. Omron Healthcare Inc.
- 11.2.12. Pfizer
- 11.2.13. St. Jude Medical LLC
- 11.2.14. Stimwave LLC
- 11.2.15. Others